» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
The aim of this study is comparing efficacy of two treatment methods including oral azithromycin and cryotherapy in children with cutaneous leishmaniasis caused by leishmania tropica. Sixty six patients below 14 years old (two groups with 33 individuals) that their cutaneous leishmaniasis have been diagnosed by direct skin smear (Giemsa staining method) or skin biopsy and their clinical lesion have longed less than 6 months will enter to study. The first group will be treated with oral azithromycin 10-12mg/kg daily up to 10 days in first session and then it will be repeated during 3 following periods. The second group will be treated with cryotherapy 10-20 s weekly, until the lesion with 1 mm of its surrounding are completely infiltrated. The result will be recorded as changes of lesion indurations basis in each follow up visit. Patients will be followed for 3 months after finishing treatment and lesion indurations and possible side effects will be recorded.
IRCTID: IRCT138903023862N3
  1. Comparing efficacy of combined cryotherapy and interalesional meglumine antimoniate (Glucantime) vs. cryotherapy and interalesional meglumine antimoniate alone for the treatment of cutaneous leishmaniasis
  2. Comparing improvement of lesions in leishmaniasis patients with two treatment methods including trichloroacetic Acid (TCA) and interalesional meglumine antimoniate (Glucantime) for the treatment of Lupoid leishmaniasis
  3. Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
  4. Efficacy of Topical Liposomal Azithromycin versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
  5. Evaluating the effectiveness of intralesional injection of Glucantime® plus cotton boll extract compared to intralesional injection of Glucantime® plus cryotherapy in patients infected with Leishmania tropica
  6. Determination of the efficacy of cryotherapy plus topical Juniperus excelsa M.Bieb, based on traditional Persian medicine, versus cryotherapy alone in the treatment of cutaneous leishmaniasis: a double-blind randomized clinical trial
  7. The Effect of Berberis Vulgaris hydro alcoholic extract, On Cutaneous Leishmaniasis patients in comparison with Glucantime and Placebo: A Clinical Trial
  8. Evaluation of theraputic response to systemic Meglumine antimoniate (Glucantime) in children with acute Cutaneous Leishmaniasis comparing with adult patients
  9. Randomized, double blind, clinical trial on efficacy of topical nano-liposomal amphotericin B for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica (Phase 3)
  10. Assessment of the efficacy of Gentian violet accompanied with cryotherapy in the treatment of old world cutaneous leishmaniasis
Loading...